While molecular effects of ST6GAL1 have not been well-studied in BTICs, studies in other tumor types have demonstrated sialylation of a select group of cell surface molecules that are known to play critical roles in brain tumors. This evidence concerns the gene ST6GAL1 and brain neoplasm.